Interest of next-generation sequencing in BCG-treated high-risk bladder cancer.

CONCLUSION: Next generation sequencing in NMIBC could be a supplementary aid in treatment decision making in the future. In an area where personalized medicine is rapidly growing in importance we need larger studies to define molecular characteristics in tumours to detect genomic associations between clinical phenotypes and recurrence or progression of the disease. LEVEL OF EVIDENCE: 3. PMID: 29673906 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29673906?dopt=Abstract

Source: Progres en Urologie - April 22, 2018 Category: Urology & Nephrology Tags: Prog Urol Source Type: research